1Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274: 1672-1677.
2Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase(CDKs), growth suppressor and cyclin dependent kinase inhibitors(CDKIs) [J]. J Oncogene,1995, 11:211 -219.
3Kamb A. Cell-cycle regulators and cancer[J]. J Trends Genet,1995, 11: 136- 140.
4Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27^kipl in multistage colorectal carcinogenesis[J].Cancer Res, 1998, 58:114 - 122.
5Hunter T, Pines J. Cyelins and cancer Ⅱ: Cyclins and CDK inhibitors come of age[J]. Cell, 1994,79:573 -576.
6Clurman BE, Roberts JM. Cell cycle and cancer[J]. J National Cancer Institute, 1995, 87:1499 - 1504.
7Matsuoka S, Edwards MC, Bai C, et al. p57^juo2 a structurally distinct member is a candidate tumor suppressor gene[J]. Genes Dev, 1995, 9:650 - 662.
8Orlow 1, lavarone A, Crider-Miller SJ, et al. Cyclin-dependent kinase inhibitor p57^kip2 in soft tissue sarcoma and Wilms tumor[J].Cancer Res, 1996, 56:1219 - 1221.
9Lee MH, Reynisdottir I, Massague J. Cloning of p57^kip2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distrlbution[J]. Genes Dev, 1995, 9:639-649.
10Kondo M, Matsuka S, Uchida K, et al. Selective maternal allele loss in human lung cancers of the maternally expressed p57^kip2 gene at 11p15.5[J]. Oncogen, 1996,12:1365-1368.
9Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA mieroarray[J]. Science, 1995,270(20) : 467-470.
10Baritaki S, Huerta-Yepez S, Sakai T, et al. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: upregulation of DR5 and inhibition of Yin Yang 1[J]. Mol Cancer Ther,2007,6(4) : 1387-1399.
